Major depressive disorder, recurrent, moderate
Conditions
Interventions
This is a randomized clinical trial with two groups. BATD-R + reminder group: 18 female and male participants will complete three or five baseline sessions (random assignment), followed by six session
L01.462.500.847.698.300.500
Sponsors
Instituto Brasiliense de Análise do Comportamento
Instituto Brasiliense de Análise do Comportamento
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Ages between 18 and 60 years; both genders; meet the criteria for Major Depressive Disorder according to the DSM-5; have a score above 16 on the Hamilton Scale for Depression (GRID-HAM-D); literate Brazilians; use Whatsapp daily in their communications; schedule compatibility with research therapists; access to a computer, notebook, tablet or smartphone with a camera and internet connection; access to a confidential and suitable environment for carrying out teleservices; using antidepressants for at least two months or not using antidepressants for the same amount of time
Exclusion criteria
Exclusion criteria: Being in psychotherapeutic treatment; being diagnosed with bipolar disorder; being diagnosed with psychotic disorders; being diagnosed with current abuse/dependence on psychoactive substances; being at high risk of suicide (according to the diagnostic interview)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We expect a reduction in depression level on the Hamilton Depression Rating Scale (HAM-D) from moderate (score 17 to 24) to mild (below 16) or normal (below 8) between pre-test and post-test. ;The Behavioral Activation Depression Scale – Short Form (BADS-SF) will measure behaviors each week from baseline until one week after the last intervention session; a gradual increase in the 7-point Likert scale is expected after the start of the intervention, reflecting an increase in active behaviors and a reduction in avoidance behaviors of participants. | — |
Secondary
| Measure | Time frame |
|---|---|
| We expect a reduction in the Depression, Anxiety and Stress Scale (DASS-21) in pre- and post-intervention measurements.;We expect an increase in the World Health Organization's brief assessment of quality of life (WHOQOL-bref) in pre- and post-intervention measurements. | — |
Countries
Brazil
Contacts
Public ContactRenata Penna Borges Nunes Cambraia
Instituto Brasiliense de Análise do Comportamento
Outcome results
None listed